Filling the gap between traditional Chinese medicine and modern medicine, are we heading to the right direction?

Complementary Therapies in Medicine

Volumn 21, Issue 3, 2013, Pages 272-275

  Chen, Xiuping ^a   Pei, Lixia ^b   Lu, Jinjian ^a  

^a University of Macau   (Macao)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Gap; Intelligent mixture; Modern medicine; Research strategy; Traditional Chinese medicine

Indexed keywords

ARSENIC DERIVATIVE; ARSENIC TRIOXIDE; ARTEMISININ; BERBERINE; CURCUMIN; EPHEDRINE; HERBACEOUS AGENT; INDIRUBIN; ORIDONIN; TANSHINONE IIA; TETRAARSENIC TETRASULFIDE; UNCLASSIFIED DRUG;

BIOMEDICINE; CHINA; CHINESE HERB; CHINESE MEDICINE; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DRUG POTENTIATION; HERBAL MEDICINE; HIGH THROUGHPUT SCREENING; LETTER; MALARIA; MODERN MEDICINE; PROMYELOCYTIC LEUKEMIA;

CHINA; DELIVERY OF HEALTH CARE; DRUG COMBINATIONS; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; PHYTOTHERAPY; PLANTS, MEDICINAL; RESEARCH;

EID: 84877138590     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2013.01.001     Document Type: Letter

References (29)

1. Hard to swallow. Nature 2007, 448:105-106.
2. Powell B.L. Arsenic trioxide in acute promyelocytic leukemia: potion not poison. Expert Review of Anticancer Therapy 2011, 11:1317-1319.
3. Klayman D.L. Qinghaosu (artemisinin): an antimalarial drug from China. Science 1985, 228:1049-1055.
4. Qiu J. China plans to modernize traditional medicine. Nature 2007, 446:590-591.
5. Stone R., Biochemistry Lifting the veil on traditional Chinese medicine. Science 2008, 319:709-710.
6. Mullard A. 2011 FDA drug approvals. Nature Reviews Drug Discovery 2012, 11:91-94.
7. Strohl W.R. The role of natural products in a modern drug discovery program. Drug Discovery Today 2000, 5:39-41.
8. Chen K.K., Schmidt C.F. The action of ephedrine, the active principle of the Chinese drug Ma Huang. Journal of Pharmacology and Experimental Therapeutics 1924, 24:339-357.
9. Zhu Y., Zhang Z., Zhang M., Mais D.E., Wang M.W. High-throughput screening for bioactive components from traditional Chinese medicine. Combinatorial Chemistry and High Throughput Screening 2010, 13:837-848.
10. Yan X., Liu C. High content screening analysis for systematic study on traditional Chinese medicine. Chinese Traditional and Herbal Drugs 2008, 39:1121-1124.
11. Li D.C., Zhong X.K., Zeng Z.P., Jiang J.G., Li L., Zhao M.M., et al. Application of targeted drug delivery system in Chinese medicine. Journal of Controlled Release 2009, 138:103-112.
12. Liu X., Guo D.A. Application of proteomics in the mechanistic study of traditional Chinese medicine. Biochemical Society Transactions 2011, 39:1348-1352.
13. Zhang A., Sun H., Wang Z., Sun W., Wang P., Wang X. Metabolomics: towards understanding traditional Chinese medicine. Planta Medica 2010, 76:2026-2035.
14. Wang X., Sun H., Zhang A., Sun W., Wang P., Wang Z. Potential role of metabolomics approaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine. Journal of Pharmaceutical and Biomedical Analysis 2011, 55:859-868.
15. van der Greef J., van Wietmarschen H., Schroen J., Wang M., Hankemeier T., Xu G. Systems biology-based diagnostic principles as pillars of the bridge between Chinese and Western medicine. Planta Medica 2010, 76:2036-2047.
16. Li S. Network target: a starting point for traditional Chinese medicine network pharmacology. Zhongguo Zhong Yao Za Zhi 2011, 36:2017-2020.
17. Neill U.S. From branch to bedside: Youyou Tu is awarded the 2011 Lasker-DeBakey Clinical Medical Research Award for discovering artemisinin as a treatment for malaria. Journal of Clinical Investigation 2011, 121:3768-3773.
18. Chen X., Pei L., Wang Y. Discussion on research and development models in innovative Chinese Materia Medica. Chinese Traditional and Herbal Drugs 2011, 42:1255-1260.
19. Shoemaker R.H. The NCI60 human tumour cell line anticancer drug screen. Nature Reviews Cancer 2006, 6:813-823.
20. Liang X.M., Xu Q., Xue X.Y., Zhang F.F., Xiao Y.S. Systematic research on the multi-component Chinese medicine. World Science and Technology-Modernization of Traditional Chinese Medicine and Materia Medica 2006, 8.
21. Zhang B.L., Wang Y.Y. The fundamental study on critical scientific problem of prescriptions. Chinese Journal of Natural Medicines 2005, 3.
22. Wang L., Zhou G.B., Liu P., Song J.H., Liang Y., Yan X.J., et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:4826-4831.
23. Ghosh S., Basu A. Network medicine in drug design: implications for neuroinflammation. Drug Discovery Today 2012, 17:600-607.
24. Li S., Zhang B., Jiang D., Wei Y., Zhang N. Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae. BMC Bioinformatics 2010, 11(Suppl. 11):S6.
25. Li S., Zhang B., Zhang N. Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Systems Biology 2011, 5(Suppl. 1):S10.
26. Lam W., Bussom S., Guan F., et al. The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Science Translational Medicine 2010, 2:45ra59.
27. Scheid V. The globalization of Chinese medicine. Lancet 1999, 354(Suppl.):SIV10.
28. Keith C.T., Borisy A.A., Stockwell B.R. Multicomponent therapeutics for networked systems. Nature Reviews Drug Discovery 2005, 4:71-78.
29. Ashley C.E., Carnes E.C., Phillips G.K., et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nature Materials 2011, 10:389-397.